{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T03:42:26Z","timestamp":1790221346703,"version":"4.1.0"},"reference-count":31,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,5]]},"abstract":"<jats:sec>\n            <jats:title>Background.<\/jats:title>\n            <jats:p>Regarding patients with severe aplastic anemia (SAA) who fail immunosuppressive therapy and lack an HLA-matched sibling donor (MSD), the best alternative donor including unrelated (URD) and haploidentical (HAPLO) donors for allogeneic stem cell transplantation (SCT) remains to be established.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods.<\/jats:title>\n            <jats:p>We analyzed the comprehensive outcomes of 153 consecutive adult SAA patients treated with SCT from alternative donors: 73 HLA-well matched (8\/8) URDs (WM-URDs), 34 mismatched (6-7\/8) URDs (MM-URDs), and 46 HAPLOs.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results.<\/jats:title>\n            <jats:p>Neutrophil\/platelet engraftments were achieved at a median of 11\/15 days for WM-URDs, 13\/16.5 days for MM-URDs, and 12\/14 days for HAPLOs, respectively. The 3-year overall survival (OS), failure-free survival, cumulative incidence of graft-failure, and transplant-related mortality were statistically not different among the 3 groups: 90.3%, 87.5%, 2.7%, and 9.8% for WM-URDs; 85.3%, 81.7%, 0%, and 14.7% for MM-URDs, and 84.4%, 82.3%, 6.5%, and 11.2% for HAPLOs, respectively. The rates of other complications, including graft-versus-host disease, cytomegalovirus DNAemia, hemorrhagic cystitis, invasive fungal disease, secondary malignancies, and sinusoidal obstruction syndrome, were also statistically not different. Subgroup analysis of the MM-URD group showed that the 3-year OS of patients receiving SCTs from 6\/8-URDs were worse than those receiving SCTs from 7\/8-URDs (75.0% versus 94.4%, <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.26).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions.<\/jats:title>\n            <jats:p>There was no significant difference in the SCT outcomes with WM-URDs, MM-URDs, or HAPLO donors. The clinician can make the best choice among these alternative donor sources based on the host\/donor features and the urgency of the need for SCT. However, the selection of 6\/8-URDs should be avoided due to inferior survival outcomes.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/tp.0000000000003342","type":"journal-article","created":{"date-parts":[[2020,7,6]],"date-time":"2020-07-06T21:01:38Z","timestamp":1594069298000},"page":"1097-1105","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":7,"title":["Comparable Outcomes Between Unrelated and Haploidentical Stem Cell Transplantation in Adult Patients With Severe Aplastic Anemia"],"prefix":"10.1097","volume":"105","author":[{"given":"Sung-Soo","family":"Park","sequence":"first","affiliation":[{"name":"Department of Hematology, Seoul St. Mary\u2019s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gi June","family":"Min","sequence":"additional","affiliation":[{"name":"Department of Hematology, Seoul St. Mary\u2019s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Park","sequence":"additional","affiliation":[{"name":"Department of Hematology, Seoul St. Mary\u2019s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung-Eun","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Hematology, Seoul St. Mary\u2019s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae-Ho","family":"Yoon","sequence":"additional","affiliation":[{"name":"Department of Hematology, Seoul St. Mary\u2019s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seung Hwan","family":"Shin","sequence":"additional","affiliation":[{"name":"Department of Hematology, Eunpyeong St. Mary\u2019s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Byung-Sik","family":"Cho","sequence":"additional","affiliation":[{"name":"Department of Hematology, Seoul St. Mary\u2019s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ki-Seong","family":"Eom","sequence":"additional","affiliation":[{"name":"Department of Hematology, Seoul St. Mary\u2019s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoo-Jin","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Hematology, Seoul St. Mary\u2019s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seok","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Hematology, Seoul St. Mary\u2019s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang-Ki","family":"Min","sequence":"additional","affiliation":[{"name":"Department of Hematology, Seoul St. Mary\u2019s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hee-Je","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Hematology, Seoul St. Mary\u2019s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seok-Goo","family":"Cho","sequence":"additional","affiliation":[{"name":"Department of Hematology, Seoul St. Mary\u2019s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jong Wook","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Hematology, Seoul St. Mary\u2019s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2020,6,29]]},"reference":[{"key":"R1-20250604","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/bjh.13853","article-title":"Guidelines for the diagnosis and management of adult aplastic anaemia.","volume":"172","author":"Killick","year":"2016","journal-title":"Br J Haematol"},{"key":"R2-20250604","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1182\/blood-2016-08-693481","article-title":"How I treat acquired aplastic anemia.","volume":"129","author":"Bacigalupo","year":"2017","journal-title":"Blood"},{"key":"R3-20250604","doi-asserted-by":"crossref","first-page":"713","DOI":"10.3904\/kjim.2014.29.6.713","article-title":"Recent advances in treatment of aplastic anemia.","volume":"29","author":"Shin","year":"2014","journal-title":"Korean J Intern Med"},{"key":"R4-20250604","doi-asserted-by":"crossref","first-page":"4576","DOI":"10.1182\/blood-2007-06-097386","article-title":"High-resolution donor-recipient HLA matching contributes to the success of unrelated donor marrow transplantation.","volume":"110","author":"Lee","year":"2007","journal-title":"Blood"},{"key":"R5-20250604","doi-asserted-by":"crossref","first-page":"976","DOI":"10.3324\/haematol.2009.018267","article-title":"Fludarabine, cyclophosphamide, antithymocyte globulin, with or without low dose total body irradiation, for alternative donor transplants, in acquired severe aplastic anemia: a retrospective study from the EBMT-SAA Working Party.","volume":"95","author":"Bacigalupo","year":"2010","journal-title":"Haematologica"},{"key":"R6-20250604","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/j.bbmt.2008.04.003","article-title":"Classification of HLA-matching for retrospective analysis of unrelated donor transplantation: revised definitions to predict survival.","volume":"14","author":"Weisdorf","year":"2008","journal-title":"Biol Blood Marrow Transplant"},{"key":"R7-20250604","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1182\/blood-2011-11-354563","article-title":"Selection of optimal alternative graft source: mismatched unrelated donor, umbilical cord blood, or haploidentical transplant.","volume":"119","author":"Ballen","year":"2012","journal-title":"Blood"},{"key":"R8-20250604","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1002\/ajh.25257","article-title":"Optimal conditioning regimen for haplo-identical stem cell transplantation in adult patients with acquired severe aplastic anemia: Prospective de-escalation study of TBI and ATG dose.","volume":"93","author":"Lee","year":"2018","journal-title":"Am J Hematol"},{"key":"R9-20250604","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1056\/NEJMra1413485","article-title":"Aplastic anemia.","volume":"379","author":"Young","year":"2018","journal-title":"N Engl J Med"},{"key":"R10-20250604","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1016\/j.bbmt.2017.05.026","article-title":"Beneficial role of low-dose antithymocyte globulin in unrelated stem cell transplantation for adult patients with acquired severe aplastic anemia: reduction of graft-versus-host disease and improvement of graft-versus-host disease-free, failure-free survival rate.","volume":"23","author":"Park","year":"2017","journal-title":"Biol Blood Marrow Transplant"},{"key":"R11-20250604","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.bbmt.2010.06.014","article-title":"The outcome of unrelated hematopoietic stem cell transplants with total body irradiation (800 cGy) and cyclophosphamide (120 mg\/kg) in adult patients with acquired severe aplastic anemia.","volume":"17","author":"Lee","year":"2011","journal-title":"Biol Blood Marrow Transplant"},{"key":"R12-20250604","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1182\/blood.V48.1.63.63","article-title":"Severe aplastic anemia: a prospective study of the effect of early marrow transplantation on acute mortality.","volume":"48","author":"Camitta","year":"1976","journal-title":"Blood"},{"key":"R13-20250604","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.hoc.2009.01.005","article-title":"Diagnosis and treatment of acquired aplastic anemia.","volume":"23","author":"Bacigalupo","year":"2009","journal-title":"Hematol Oncol Clin North Am"},{"key":"R14-20250604","doi-asserted-by":"crossref","first-page":"e4914","DOI":"10.1097\/MD.0000000000004914","article-title":"Ginseng for managing menopausal woman\u2019s health: A systematic review of double-blind, randomized, placebo-controlled trials.","volume":"95","author":"Lee","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"R15-20250604","doi-asserted-by":"crossref","first-page":"2912","DOI":"10.1182\/blood-2005-05-2004","article-title":"Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT.","volume":"106","author":"Sorror","year":"2005","journal-title":"Blood"},{"key":"R16-20250604","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1182\/blood.V73.2.606.606","article-title":"Graft failure following bone marrow transplantation for severe aplastic anemia: risk factors and treatment results.","volume":"73","author":"Champlin","year":"1989","journal-title":"Blood"},{"key":"R18-20250604","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1086\/588660","article-title":"Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer\/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC\/MSG) Consensus Group.","volume":"46","author":"De Pauw","year":"2008","journal-title":"Clin Infect Dis"},{"key":"R19-20250604","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.bbmt.2015.09.001","article-title":"International, multicenter standardization of acute graft-versus-host disease clinical data collection: a report from the mount sinai acute GVHD international consortium.","volume":"22","author":"Harris","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"key":"R20-20250604","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.bbmt.2014.12.035","article-title":"2014 National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: preface to the series.","volume":"21","author":"Pavletic","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"R21-20250604","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1182\/blood.V94.4.1465","article-title":"Risk factors for acute graft-versus-host disease after allogeneic blood stem cell transplantation.","volume":"94","author":"Przepiorka","year":"1999","journal-title":"Blood"},{"key":"R22-20250604","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1182\/blood-2001-11-0057","article-title":"Risk factors for acute graft-versus-host disease in patients undergoing transplantation with CD34+ selected blood cells from HLA-identical siblings.","volume":"100","author":"Urbano-Ispizua","year":"2002","journal-title":"Blood"},{"key":"R23-20250604","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1182\/blood.V98.7.2043","article-title":"Donor characteristics as risk factors in recipients after transplantation of bone marrow from unrelated donors: the effect of donor age.","volume":"98","author":"Kollman","year":"2001","journal-title":"Blood"},{"key":"R24-20250604","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/bjh.14225","article-title":"Haplo-identical transplantation for acquired severe aplastic anaemia in a multicentre prospective study.","volume":"175","author":"Xu","year":"2016","journal-title":"Br J Haematol"},{"key":"R25-20250604","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1016\/j.bbmt.2014.06.028","article-title":"Nonmyeloablative peripheral blood haploidentical stem cell transplantation for refractory severe aplastic anemia.","volume":"20","author":"Clay","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"key":"R26-20250604","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/bmt.2013.224","article-title":"Long-term outcome of HLA-haploidentical hematopoietic SCT without in vitro T-cell depletion for adult severe aplastic anemia after modified conditioning and supportive therapy.","volume":"49","author":"Gao","year":"2014","journal-title":"Bone Marrow Transplant"},{"key":"R27-20250604","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/bmt.2015.20","article-title":"Haploidentical BMT and post-transplant Cy for severe aplastic anemia: a multicenter retrospective study.","volume":"50","author":"Esteves","year":"2015","journal-title":"Bone Marrow Transplant"},{"key":"R28-20250604","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1016\/j.bbmt.2018.05.015","article-title":"Unmanipulated haploidentical hematopoietic stem cell transplantation achieved outcomes comparable with matched unrelated donor transplantation in young acquired severe aplastic anemia.","volume":"24","author":"Lu","year":"2018","journal-title":"Biol Blood Marrow Transplant"},{"key":"R29-20250604","doi-asserted-by":"crossref","first-page":"644","DOI":"10.3324\/haematol.2015.139469","article-title":"Allogeneic unrelated bone marrow transplantation from older donors results in worse prognosis in recipients with aplastic anemia.","volume":"101","author":"Arai","year":"2016","journal-title":"Haematologica"},{"key":"R30-20250604","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s13045-017-0398-y","article-title":"Upfront haploidentical transplant for acquired severe aplastic anemia: registry-based comparison with matched related transplant.","volume":"10","author":"Xu","year":"2017","journal-title":"J Hematol Oncol"},{"key":"R31-20250604","doi-asserted-by":"crossref","first-page":"884","DOI":"10.3324\/haematol.2015.138727","article-title":"Unrelated alternative donor transplantation for severe acquired aplastic anemia: a study from the French Society of Bone Marrow Transplantation and Cell Therapies and the EBMT Severe Aplastic Anemia Working Party.","volume":"101","author":"Devillier","year":"2016","journal-title":"Haematologica"},{"key":"R32-20250604","doi-asserted-by":"crossref","first-page":"3186","DOI":"10.1182\/blood-2011-04-349316","article-title":"Acceptable HLA-mismatching in unrelated donor bone marrow transplantation for patients with acquired severe aplastic anemia.","volume":"118","author":"Yagasaki","year":"2011","journal-title":"Blood"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0000000000003342","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T19:07:49Z","timestamp":1749064069000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0000000000003342"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,29]]},"references-count":31,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/tp.0000000000003342","relation":{},"ISSN":["0041-1337"],"issn-type":[{"value":"0041-1337","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6,29]]}}}